Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $325.0000 (-14.47%) ($300.0000 - $375.0000) on Wed. Dec. 3, 2008. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 11.16% (three month average) | RSI | 21 | Latest Price | $325.0000(-14.47%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -6.9% a day on average for past five trading days. | Weekly Trend | CAPR declines -27% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(3%) XOP(3%) EWI(2%) EWP(2%) IWM(2%) | Factors Impacting CAPR price | CAPR will decline at least -5.58% in a week (0% probabilities). EWY(-1%) XLU(0%) XLP(0%) VWO(-0%) TLT(0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -5.58% (StdDev 11.16%) | Hourly BBV | 0 () | Intraday Trend | -13.3% | | | |
|
Resistance Level | $693.28 | 5 Day Moving Average | $407(-20.15%) | 10 Day Moving Average | $424.42(-23.42%) | 20 Day Moving Average | $693.28(-53.12%) | To recent high | -87.3% | To recent low | 0% | Market Cap | $6.402b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |